Form 4 for IRD Opus Genetics, Inc.
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-10 · accession 0001140361-23-001520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-12 | 2023-01-10 | IRD | Sooch Mina | Pres, CEO, Dir | A - Grant | $0.00 | +134.5K | 430.5K | +45% | $0 |
| D | 2023-01-12 | 2023-01-10 | IRD | Sooch Mina | Pres, CEO, Dir | A - Grant | $0.00 | +201.7K | 201.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-10 | A | A | 134,456 | $0.00 | 430,501 | D | — | — | (F1) Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-01-10 | A | A | 201,683 | $0.00 | 201,683 | D | $3.50 · — to 2033-01-09 | 201,683 Common Stock | (F2) The option will vest with respect to 50,420 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter. |